Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management (Q43188730)

15 November 2017

Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management (English)

1 reference

15 November 2017

1 reference

restless legs syndrome

1 reference

Magdolna Hornyak

1

1 reference

15 November 2017

1 February 2010

1 reference

15 November 2017

1 reference

15 November 2017

24

1 reference

15 November 2017

2

1 reference

15 November 2017

89-98

1 reference

https://scigraph.springernature.com/pub.10.2165/11317500-000000000-00000

15 November 2017

0 references

cites work

SYMPTOM OF RESTLESS LEGS.

1 reference

https://api.crossref.org/works/10.2165%2F11317500-000000000-00000

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11317500-000000000-00000

Marked reduction in indexes of dopamine metabolism among patients with depression who attempt suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11317500-000000000-00000

Worsening of autosomal dominant restless legs syndrome after use of mirtazapine: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11317500-000000000-00000

Restless Legs Syndrome is Associated with DSM-IV Major Depressive Disorder and Panic Disorder in the Community

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11317500-000000000-00000

EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls

21 January 2018

1 reference

12 December 2020

Insomnia and comorbid psychiatric disorders

1 reference

12 December 2020

Mirtazapine may have the propensity for developing a restless legs syndrome? A case report

1 reference

12 December 2020

Cognitive behavioural group therapy to improve patients' strategies for coping with restless legs syndrome: a proof-of-concept trial.

1 reference

12 December 2020

Longitudinal effects of nortriptyline on EEG sleep and the likelihood of recurrence in elderly depressed patients

1 reference

12 December 2020

Epidemiology of restless legs symptoms in adults.

1 reference

12 December 2020

Bupropion may improve restless legs syndrome: a report of three cases

1 reference

12 December 2020

Mirtazapine and restless leg syndrome: a case report

1 reference

12 December 2020

"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

1 reference

12 December 2020

Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey

1 reference

12 December 2020

Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort.

1 reference

12 December 2020

Sleep disorders and depressive feelings: a global survey with the Beck depression scale

1 reference

12 December 2020

Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome.

1 reference

12 December 2020

Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers

1 reference

12 December 2020

EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep

1 reference

12 December 2020

Fluoxetine-mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial.

1 reference

12 December 2020

Symptoms of restless legs syndrome in older adults: outcomes on sleep quality, sleepiness, fatigue, depression, and quality of life.

1 reference

12 December 2020

Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?

1 reference

12 December 2020

Clinical guideline for the evaluation and management of chronic insomnia in adults.

1 reference

12 December 2020

Restless legs syndrome in 218 patients: associated disorders.

1 reference

12 December 2020

Does domperidone potentiate mirtazapine-associated restless legs syndrome?

1 reference

12 December 2020

Restless legs syndrome prevalence and impact: REST general population study

1 reference

12 December 2020

Fluoxetine-induced sleep disturbance in depressed patients.

1 reference

12 December 2020

Fluoxetine and restless legs syndrome

1 reference

12 December 2020

Prevalence of restless legs syndrome and periodic limb movement disorder in the general population

1 reference

12 December 2020

Antidepressants and periodic leg movements of sleep

1 reference

12 December 2020

Restless legs syndrome, periodic limb movements, and psychopharmacology

1 reference

12 December 2020

Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls

1 reference

12 December 2020

Antidepressant medication use and restless legs syndrome in patients presenting with insomnia

1 reference

12 December 2020

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

12 December 2020

Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation

1 reference

12 December 2020

Psychosocial risk factors for depressive disorders in late life

1 reference

12 December 2020

Pramipexole in psychiatry: a systematic review of the literature.

1 reference

12 December 2020

Restless legs syndrome induced by citalopram: a psychiatric emergency?

1 reference

12 December 2020

The restless legs syndrome

1 reference

12 December 2020

Sex and the risk of restless legs syndrome in the general population

1 reference

12 December 2020

[Depression in restless legs syndrome. Pathogenesis, assessment, and implications for treatment]

1 reference

12 December 2020

Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone

1 reference

12 December 2020

Mianserin-induced restless legs syndrome

1 reference

12 December 2020

Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll.

1 reference

12 December 2020

Restless legs syndrome as side effect of second generation antidepressants

1 reference

12 December 2020

Modeling the causal relationships between symptoms associated with restless legs syndrome and the patient-reported impact of RLS.

1 reference

12 December 2020

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

12 December 2020

Comorbidity in restless legs syndrome among a sample of Swedish adults

1 reference

12 December 2020

Assessing health-related quality of life in patients with restless legs syndrome.

1 reference

12 December 2020

Primary insomnia: a risk factor to develop depression?

1 reference

12 December 2020

Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes

1 reference

12 December 2020

Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study

1 reference

12 December 2020

Restless legs syndrome, periodic limb movements in sleep, and depression

1 reference

12 December 2020

Restless legs syndrome and paroxetine

1 reference

12 December 2020

Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants.

1 reference

12 December 2020

Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions

1 reference

12 December 2020

PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome

1 reference

12 December 2020

Evaluating the quality of life of patients with restless legs syndrome.

1 reference

12 December 2020

Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community

1 reference

12 December 2020

Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine.

1 reference

12 December 2020

Spinal Cord Mechanisms in Amitriptyline Responsive Restless Legs Syndrome in Parkinson's Disease

1 reference

12 December 2020

Mianserin and restless legs

1 reference

12 December 2020

A genetic risk factor for periodic limb movements in sleep

1 reference

12 December 2020

Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?

1 reference

12 December 2020

Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.

1 reference

12 December 2020

The association of depression and anxiety with medical symptom burden in patients with chronic medical illness

1 reference

12 December 2020

Restless leg syndrome exacerbated by sertraline

1 reference

12 December 2020

Restless legs syndrome induced by mirtazapine.

1 reference

12 December 2020

10.2165/11317500-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20088617

Dimensions Publication ID

15 November 2017

1015084886

0 references

Fatcat ID

release_sqhiortizndcfbqd7tpufm62ti

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sqhiortizndcfbqd7tpufm62ti

24 November 2022

mapped directly with Wikidata item

PubMed ID

20088617

1 reference

PubMed ID

20088617